Google unveiled new AI tools that proposed a novel drug combination for detecting cancer.
The AI, named Cell2Sentence-Scale 27B (C2S-Scale), identified a drug effective in laboratory conditions that human experts were unaware of.
C2S-Scale is a 27-billion-parameter foundation model designed to understand the language of individual cells.
The AI model zeroed in on a chemical drug called silmitasertib that boosts the immune system when it suspects a tumour.
Detailed Insights:
The C2S-Scale 27B model was tasked to find a drug that boosts immune signals only if low levels of interferon are present.
Researchers exposed the 27-billion parameter model to real-world patient samples with tumour-immune interactions plus low-level interferon signalling and cell-line data with no immune context.
The model simulated the effect of over 4,000 drugs and noted how many of them worked in situations where interferon levels were low even as the tumours grew.
The discovery may reveal a promising new pathway for developing therapies to fight cancer, pending more pre-clinical and clinical tests.
The strategy was to force nascent tumours to display immune-triggering signals through a process called antigen presentation.
Scientific/Technical Concepts Involved:
Antigen presentation: A process where cells display antigens on their surface to trigger an immune response.
Interferon: Proteins produced by the body that act as frontline defenders against infections and tumours.
AI: The theory and development of computer systems able to perform tasks that normally require human intelligence.